FROM THE VIDEO...
The next step is for clinical tests in humans, which should be underway thanks to a $20 million grant by the California Institute for Regenerative Medicine to move the findings to human safety tests, which was granted in 2012, after the study took place.
“We have enough data already that I can say I’m confident that this will move to phase I human trials,” said Weissman.
This is very interesting. I just wish the laws were relaxed enough to let people make the informed choice to try it for themselves so doctors could collect the data and get it on the market if findings merit it.